Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Bioequivalence study of amodiaquine hydrochloride tablets

  • In: SIG Bioavailability/Bioequivalence - Posters
  • At: Beijing (China) (2007)
  • Type: Poster
  • Poster code: BB-P-044
  • By: ZHONG, Dafang (Shanghai Institute of Materia Medica, Shanghai, China)
  • Co-author(s): Chen, Xiaoyan (Shanghai Institute of Materia Medica, SHANGHAI, China)
    Dai, Xiaojian (Shanghai Institute of Materia Medica, SHANGHAI, China)
    Gao, Zhiwei (Shanghai Institute of Materia Medica, SHANGHAI, China)
  • Abstract:

    OBJECTIVE To determine the bioequivalence of Amodiaquine Hydrochloride Tablets (test product) of Guilin Pharmaceutical Co., Ltd, China as compared to FlavoquineÂ[RSYMBOL] Tablets (reference product) of Laboratoire Aventis, France. METHODS The study was conducted as an open-label randomized, two-treatment, two-period, cross-over single-dose study..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses